The H+,K+-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole
- 5 July 1991
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42 (2) , 347-355
- https://doi.org/10.1016/0006-2952(91)90722-h
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- By 1023/SK&F 96022: Biochemistry of a novel (H+ + K+-ATPase inhibitorBiochemical Pharmacology, 1990
- Characterization of Human Microsomal Cytochrome P-450 EnzymesAnnual Review of Pharmacology and Toxicology, 1989
- The interaction of omeprazole with rat liver cytochrome P450-mediated monooxygenase reactions in vitro and in vivoBiochemical Pharmacology, 1988
- Antisecretory activity of AG-1749, a proton pump inhibitorThe Japanese Journal of Pharmacology, 1986
- Omeprazole inhibits oxidative drug metabolismGastroenterology, 1985
- Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazoleBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983
- Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPaseNature, 1981
- Kinetics of ethylmorphine N-demethylase at low substrate concentrations and its implications concerning the role of the stimulation of NADPH-cytochrome P-450 reductase activity in mixed-function oxidase activityBiochemical Pharmacology, 1977
- Proton transport by gastric membrane vesiclesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1977
- K+-stimulated ATPase in purified microsomes of bullfrog oxyntic cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973